查詢結果分析
相關文獻
- Repeat Liver Resection for Recurrent Colorectal Metastasis
- Colorectal Cancer with Resectable Liver Metastases: Surgical Resection, Radiofrequency Ablation, or Stereotactic Body Radiotherapy: Clinical Outcomes of Different Treatment Modalities
- 以肝切除治療繼發於大腸直腸癌的肝臟轉移
- Liver Resection for Hepatic Metastasis from Colorectal Carcinoma
- The Value of FDG PET/CT to Monitor Treatment Response Post ⁹°Y-Microsphere Selective Internal Radiation Therapy in Colorectal Cancer with Hepatic Metastasis: Preliminary Experience in Kaohsiung Medical University Hospital
- Liver Metastasis Originating from Colorectal Cancer with Portal Vein Tumor Thrombosis: A Case Report and Review of the Literature
- 轉移性或復發性大腸直腸癌的前導性化學治療簡介
- 轉移性肝腫瘤的治療及微創手術的應用
- The Short-term Outcomes of Laparoscopic Radiofrequency Ablation Combined with Hepatic Resection versus Hepatic Resection Alone for Patients with Colorectal Liver Metastases
- Simultaneous Resection for Patient with Resectable Synchronous Colorectal Cancer and Liver Metastasis, Comparing the Result between Laparotomy and Laparoscopic Groups: Our Experience at Chi-Mei Hospital
頁籤選單縮合
| 題 名 | Repeat Liver Resection for Recurrent Colorectal Metastasis=大腸直腸癌肝轉移復發後再次肝切除 |
|---|---|
| 作 者 | 廖柏年; 林炯森; | 書刊名 | 臺灣癌症醫學雜誌 |
| 卷 期 | 29:3 2013.09[民102.09] |
| 頁 次 | 頁135-140 |
| 分類號 | 416.245 |
| 關鍵詞 | 大腸直腸癌; 肝切除; 肝轉移; Colorectal cancer; Hepatectomy; Liver metastasis; |
| 語 文 | 英文(English) |
| 中文摘要 | 在大腸直腸癌中,肝臟是最常轉移的位置。肝腫瘤切除提供一種可治癒的方式,經 肝腫瘤切除的病人五年存活率可在 40%到 60%。但是一開始即診斷大腸癌乾轉移的病人 只有 20%到 30%是一開始就可以開刀的。而即使在肝切除之後,大腸直腸癌復發的機率 依然很高,其中有 30%的人依然只有復發肝轉移。再切除肝腫瘤並不常見,但在一些謹 慎評估過的病人身上,依然是可選擇的治療方式。我們報告的病例,一開始診斷大腸直 腸癌時合併有肝轉移。經評估後認為無法完全手術切除。而在經過化學治療之後腫瘤縮 小至可開刀的程度,進而接受肝切除手術,其在一年之內肝轉移復發,再次接受肝切除 手術。術後恢復良好,至今未有其他復發的證據。我們回顧文獻認為在大腸直腸癌合併 肝轉移的病人,若肝轉移是可切除的,皆應接受手術治療,以達治癒的目的。 |
| 英文摘要 | The liver is the most common metastatic site of colorectal cancer. Hepatectomy is widely accepted as a treatment of potential cure and the 5-year survival rate is 40 to 60%. However, only 20 to 30% of patients have resectable disease initially. Even if hepatectomy can be performed, the chance of recurrence is still high throughout a patient's lifetime. About 30% of these recurrences are limited to the liver. Although repeat hepatectomy is not common, it can be considered in selected patients. Here, we report on a colorectal cancer patient initially diagnosed with unresectable liver metastasis. He underwent curative hepatectomy after chemotherapy, and received repeat hepatectomy after recurrent liver metastasis. Based on our case and review of the literature, we suggest that repeat hepatectomy is feasible in some selected patients with recurrent and resectable liver metastasis. |
本系統中英文摘要資訊取自各篇刊載內容。